Global shares went slightly down on Wednesday after slow retail sales in the U.S. worried the markets. Also, rising coronavirus cases keep threatening fragile economic recovery, damping the euphoria from vaccine hope optimism.
The retail sales report showed that customers’ spending slowed down. The holiday shopping season is ahead, and the lack of a new fiscal stimulus from Washington is not painting an an-all-good picture for the economy.
Bitcoin broke records and skyrocketed more than 3% reaching $18,293. The Bitcoin price is getting very close to its peak in December 2017 when it was around $20,000; the news that initiated the bull run came after PayPal allowing its customers to use the cryptocurrency on its network.
The reason why Bitcoin is going up may vary but the main reason lies with governments printing fiat money now. Since the start of the pandemic, there has been concern about overprinting money by central banks worldwide which could end up devaluating fiat currencies.
The oil process eased a bit more than expected on the hopes that OPEC will postpone its already planned January oil output increase.
A new bet from Berkshire Hathaway Inc's (N: BRKa) on the U.S. pharmaceutical industry signals a big stimulus for large drug companies' shares.
On Tuesday, drug stocks continued outperforming other stocks after the day when Warren Buffett's conglomerate revealed that he had made $5.7 billion of new investment in Abbvie Inc (N: ABBV), Bristol-Myers Squibb Co (N: BMY), Merck & Co (N: MRK), and Pfizer Inc (N: PFE), whose vaccines against COVID-19 have demonstrated high effectiveness in late-stage studies.
"It's a recognition of, 'Hey, there's some value there,'" said Walter Todd, chief investment officer at Greenwood Capital, whose funds hold shares of Pfizer, Merck, and Eli Lilly (N: LLY).
Pharma stocks received a massive boost after the November 3 U.S presidential election results; investors got a clear message that Democrats will rule the White House.